Should You Add Supernus Pharmaceuticals Inc (SUPN) Stock to Your Portfolio Monday?

Supernus Pharmaceuticals Inc (SUPN) is around the top of the Healthcare sector according to InvestorsObserver. SUPN received an overall rating of 87, which means that it scores higher than 87% of stocks. Additionally, Supernus Pharmaceuticals Inc scored a 80 in the Healthcare sector, ranking it higher than 80% of stocks in that sector.

SUPN has an Overall Score of 87. Find out what this means to you and get the rest of the rankings on SUPN!

See Full SUPN Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Supernus Pharmaceuticals Inc Stock Today?

Supernus Pharmaceuticals Inc (SUPN) stock has gained 0.37% while the S&P 500 is lower by -0.87% as of 1:21 PM on Monday, Jan 30. SUPN is higher by $0.15 from the previous closing price of $40.68 on volume of 284,812 shares. Over the past year the S&P 500 is down -10.64% while SUPN is higher by 32.35%. SUPN earned $0.62 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 65.66. Click Here to get the full Stock Report for Supernus Pharmaceuticals Inc stock.